• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Do We Need to Be Face-to-Face to Treat Alcohol Use Disorder?

Do We Need to Be Face-to-Face to Treat Alcohol Use Disorder?

February 3, 2021
Deepti Anbarasan, MD.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Deepti Anbarasan, MD. Dr. Anbarasan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Johansson M et al, Addiction 2020 Sep 24. Epub ahead of print.

The COVID-19 pandemic has highlighted the potential value of virtual treatment. This may be particularly useful for individuals with alcohol use disorder (AUD), for whom shame and stigma may limit engagement and/or retention in traditional forms of face-to-face treatment. However, an important question remains: Is virtual care, delivered via modules with which patients can engage on their own time, as effective as face-to-face care for the treatment of AUD? This study evaluated the effectiveness of internet-delivered cognitive behavioral therapy (ICBT) versus face-to-face CBT in adults with AUD using a randomized controlled design.

301 adult patients were recruited from a specialized AUD clinic in Stockholm, Sweden between 2015 and 2018. The mean age was 50 years, and 62% were male. Over two-thirds of the patients had received some college education. Subjects were randomized to either 5 modules of asynchronous therapist-guided ICBT or 5 modules of face-to-face CBT over 3 months. In the ICBT group, the therapist released pre-recorded modules one by one, and all communication between the therapist and patient occurred online asynchronously. Both groups used the same treatment material and therapists. The primary outcome was the number of drinks consumed (by self-report) in the prior week at 6-month follow-up. Secondary outcomes included the number of non-drinking days, number of binge-drinking days, average number of drinks on drinking days, and low-risk consumption in the prior week. Subjects also completed an Alcohol Use Disorders Identification Test (AUDIT) scale and answered questions about treatment satisfaction at 6 months.

In intention-to-treat analyses, the difference in alcohol use between the ICBT and face-to-face arms was non-inferior at 6-month follow-up (ICBT = 12.33 drinks in the prior week; face-to-face = 11.43). However, ICBT was inferior to face-to-face treatment in all secondary outcomes, including the total AUDIT score at 6 months (ICBT = 12.26; face-to-face = 11.57), although this difference may not be clinically meaningful. The face-to-face group rated the working alliance during treatment more highly than the ICBT group, which reported that treatment felt less personal. The ICBT group also indicated that they missed other forms of contact and viewed their treatment as less effective.

Study limitations included a high attrition rate in both groups (33% overall at 3-month follow-up and 43% at 6-month follow-up, without differences between the groups) and recruitment solely from a specialized clinical setting in which most patients were well educated and employed.

CATR’s Take
ICBT for AUD appears to be a promising treatment approach to help motivated patients reduce alcohol use and may help expand treatment to difficult-to-reach populations who have access to smartphones or other devices with video capacity. While there are some measurable—and also intangible—benefits to face-to-face care, ICBT is an important alternative for us to consider in the pandemic context and beyond.
Addiction Treatment
KEYWORDS alcohol-use-disorder quality-of-care randomized-controlled-trial telemedicine
Deepti Anbarasan, MD.

Does Pioglitazone Lead to Reduced Alcohol Use?

More from this author
www.thecarlatreport.com
Issue Date: February 3, 2021
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Pain and Addiction, CATR, January/February 2021
Kratom: A Primer
Supporting Patients With Pain and Addiction
Medical Marijuana for Chronic Pain: The Cart Before the Horse?
Medical Cannabis for Chronic Pain and Quality of Life
Do We Need to Be Face-to-Face to Treat Alcohol Use Disorder?
Featured Book
  • PracticeBoosters2e.JPG

    Psychiatry Practice Boosters, Second Edition (2018)

    Teaches you the key points of 42 of the most clinically relevant studies in psychiatry published...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • Substance_Use_Sites.jpeg
    Addiction Treatment

    Supervised Drug Consumption Sites

    Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.